Dyadic enters R&D deal for its fungus-based expression system

“There is a new kid on the block to rival E. Coli, CHO and yeast,” says Dyadic International as it collaborates to widen the use of its C1 expression tech. The collaboration aims to explore the potential of Dyadic’s C1 gene expression technology to produce an important active moiety. Confidentiality agreements restricted Dyadic CEO Mark […]

Continue Reading

New guidelines look to improve the use of patient feedback in clinical trials

Researchers have published new international guidelines for the inclusion of patient-reported outcomes in clinical trial protocols with the goal of providing high-quality evidence and enhancing patient care. “Patient-reported outcome (PRO) data from clinical trials can provide valuable evidence to inform shared decision making, labeling claims, clinical guidelines, and health policy; however, the PRO content of […]

Continue Reading

Slippery when wet: Colorcon coating aims to ease tablet swallowing

Colorcon has created a coating system it says makes swallowing tablets easier, fulfilling patient compliance demands in recent regulatory guidance. The Opadry EZ Easy Swallow Film Coating System has been launched by formulations and drug delivery tech firm Colorcon to aid patients in swallowing oral medicines. The product’s formulation contains a blend of film-former, plasticiser […]

Continue Reading

Cullinan Oncology & MABD Enter Collaboration

Cullinan Oncology and MAB Discovery GmbH (MABD), announced the initiation of a collaboration to develop novel antibody therapeutics based on MABD’s unique discovery platform. “We are excited to enter into this collaboration as the MABD development engine provides us with access to highly differentiated monoclonal antibodies” said Patrick Baeuerle, Cullinan’s chief scientific officer, Biologics. “Our […]

Continue Reading